Novel Inflammatory Biomarkers in Cardiovascular Therapeutics

Title:Novel Inflammatory Biomarkers in Cardiovascular Therapeutics

Volume: 22 Issue: 23

Author(s): Vicky Tsigkou, Gerasimos Siasos, Evangelos Oikonomou, Marina Zaromitidou, George Latsios, Manolis Vavuranakis, Spyridon Deftereos, Michael W. Cleman, Eleni Kokkou, Maria Limberi, Stathis Dimitropoulos, Thodoris Zografos, Smaragdi Marinaki, Christodoulos Stefanadis and Dimitris Tousoulis

Affiliation:

Keywords: Atherosclerosis, biomarkers, cardiovascular diseases, coronary artery disease, heart failure, hypertension, inflammation, peripheral artery disease, stroke.

Abstract: Inflammation has been established as an important determinant of cardiovascular disease progression. Currently, clinical examination, laboratory and imaging tests are invaluable for the diagnosis, prognosis and disease monitoring. Novel inflammatory biomarkers are also used to better restratify patients in risk groups but their potential to guide treatment decisions and management of patients has not been extensively evaluated. Therefore, in this review article we present the most recent data concerning the use of inflammatory biomarkers in cardiovascular therapeutics.

Cite this article as:

Tsigkou Vicky, Siasos Gerasimos, Oikonomou Evangelos, Zaromitidou Marina, Latsios George, Vavuranakis Manolis, Deftereos Spyridon, W. Cleman Michael, Kokkou Eleni, Limberi Maria, Dimitropoulos Stathis, Zografos Thodoris, Marinaki Smaragdi, Stefanadis Christodoulos and Tousoulis Dimitris, Novel Inflammatory Biomarkers in Cardiovascular Therapeutics, Current Medicinal Chemistry 2015; 22 (23) . https://dx.doi.org/10.2174/0929867322666150429110124